ERBB2 and triple-negative breast carcinoma: Luminal A (Luminal‐A‐like) was the most common type (61.8%), then Luminal B (Luminal‐B‐like) (20.0%), HER2 enriched (HER2 positive) type (9.5%), finally triple negative breast cancer or the basal type profile was noted at 8.7%.